Probiotix Health (AQSE:PBX) EV-to-EBIT : -6.13 (As of May. 11, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Probiotix Health EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Probiotix Health's Enterprise Value is £3.14 Mil. Probiotix Health's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was £-0.51 Mil. Therefore, Probiotix Health's EV-to-EBIT for today is -6.13.

The historical rank and industry rank for Probiotix Health's EV-to-EBIT or its related term are showing as below:

AQSE:PBX' s EV-to-EBIT Range Over the Past 10 Years
Min: -6.13 Med: 236.21 Max: 670.74
Current: -6.13

During the past 4 years, the highest EV-to-EBIT of Probiotix Health was 670.74. The lowest was -6.13. And the median was 236.21.

AQSE:PBX's EV-to-EBIT is ranked worse than
100% of 433 companies
in the Biotechnology industry
Industry Median: 9.43 vs AQSE:PBX: -6.13

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Probiotix Health's Enterprise Value for the quarter that ended in Jun. 2023 was £2.92 Mil. Probiotix Health's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was £-0.51 Mil. Probiotix Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was -17.54%.

Probiotix Health EV-to-EBIT Historical Data

The historical data trend for Probiotix Health's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Probiotix Health EV-to-EBIT Chart

Probiotix Health Annual Data

Trend

Dec18

Dec19

Dec20

Dec22

EV-to-EBIT

Probiotix Health Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Jun22	Dec22	Jun23
EV-to-EBIT	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Probiotix Health's EV-to-EBIT

For the Biotechnology subindustry, Probiotix Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Probiotix Health's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Probiotix Health's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Probiotix Health's EV-to-EBIT falls into.

Probiotix Health EV-to-EBIT Calculation

Probiotix Health's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	3.136	/	-0.512
	=	-6.13

Probiotix Health's current Enterprise Value is £3.14 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Probiotix Health's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was £-0.51 Mil.

Probiotix Health (AQSE:PBX) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Probiotix Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2023 )	=	EBIT	/	Enterprise Value (Q: Jun. 2023 )
	=	-0.512	/	2.91868
	=	-17.54 %

Probiotix Health's Enterprise Value for the quarter that ended in Jun. 2023 was £2.92 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Probiotix Health's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was £-0.51 Mil.

Probiotix Health EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Probiotix Health's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Probiotix Health (AQSE:PBX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Probiotix Health PLC (AQSE:PBX) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

X90:Germany

Address

Nostell Business Estate, First Floor Zucchi Suite, Wakefield, GBR, WF4 1AB

Website

https://www.probiotixhealth-ir.com

Probiotix Health PLC develops probiotics to tackle cardiovascular disease and other lifestyle conditions which are affecting growing numbers of people across the world. The Company has one class of business, in three geographical areas being that of identifying and developing microbial strains, compounds and formulations for use in the nutraceutical industry.

Probiotix Health (AQSE:PBX) Headlines

No Headlines